Southern Oncology Clinical Research Unit (SOCRU) - Phase 1 Trials Consultant or post RACP Fellowship in Medical Oncology position starting 2027
Southern Oncology Clinical Research Unit
Bedford Park, Adelaide SA
Full-time role or part-time or casual
About Southern Oncology Clinical Research Unit
Southern Oncology Clinical Research Unit (SOCRU) is a dedicated early phase clinical trials unit in the private sector. SOCRU provides people with cancer additional treatment options and the opportunity to contribute to ongoing cancer research whilst receiving the highest quality, evidence based clinical care from our skilled health professionals. Our mission is to provide outstanding care for people with cancer through the continued expansion of our unit, knowledge base and expertise.
About the Role
We are seeking an experienced and enthusiastic physician/medical oncology trainee/junior medical oncology consultant with a vision for improving medical oncology services through the provision of clinical trial treatment options for patients. This is a full-time position; however, part-time of other arrangements may be considered for the right candidate.
How to Apply
Apply via email to Dr Ganessan Kichenadasse (Ganessan.kichenadasse@socru.org.au) by submitting your cover letter addressing the key selection criteria and three key achievements in your career/or personal life. Please note that applications received without a cover letter will not be considered.
Tasks & Responsibilities
Perform delegated trial activities as sub investigators under direct supervision of principal investigators
The health screening and care of people with cancer wishing to participate in early phase clinical trials
Collecting medical history and conducting physical examinations as part of the screening, pre-treatment and outpatient process
Review of participant trial eligibility in line with Human Research Ethics Committee (HREC) approved study protocols
Reviewing pathology results, vital sign and ECG readings
Monitoring the well-being of and providing medical care to participants
Identify and report on Adverse Events and Serious Adverse Events
Oversee administration of all trial related treatments as delegated by the principal investigator
Recognise clinical deterioration of trial participants
Liaising with clinical and non-clinical staff as well as senior consultants to conduct tasks required to fulfill study protocols
Provide support for the conduct of clinical trials within SOCRU
Completion of source documentation
Key Selection Criteria:
Essential Experience
Hold a current unconditional medical registration with the Medical Board of Australia/AHPRA
Suitable for junior consultants or post RACP Medical Oncology fellows wanting exposure and training in early phase oncology trials
Good communication skills and working well in team
Desirable Experience
Advanced life support training, or willingness to undergo training
Knowledge of and training in ICH Guidelines for Good Clinical Practice (ICH-GCP)
Benefits
Receive comprehensive training in clinical trials, building your capability in a high-growth and in-demand field.
Career progression to become principal investigator for phase I cancer clinical trials
Benefit from retention bonuses that recognise your ongoing contribution and loyalty.
Enjoy the opportunity for flexible work arrangements that support your work-life balance and personal circumstances.
Access an Employee Assistance Program (EAP) offering confidential counselling and wellbeing support.
Work with an energetic and supportive team of skilled clinical research professionals who are passionate about making a difference.
Learn from experienced clinicians and researchers in early phase oncology trials.
Contribute directly to cutting-edge cancer research and the development of novel cancer therapies.
Develop your skills in managing toxicities from innovative treatments such as cell therapies, immunotherapy, oncolytic viruses, small molecules, and monoclonal antibodies.
Immerse yourself in the vibrant lifestyle of Adelaide, with access to beautiful beaches, world-renowned wine regions, and a thriving arts and culture scene.
Closing date: 30th of June 2026